Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 2.715\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CC(C)NC(=O)C1=NN(c2ccccc2)C(=O)CC1
(b) CC(C)C(NC(=O)c1ccc(C(C)(C)C)cc1)C(=O)NCC1(N(C)C)CCCCC1
(c) Nc1nc(CSC(=S)N2CCOCC2)nc(Nc2ccc(F)cc2)n1
Answer: c. Nc1nc(CSC(=S)N2CCOCC2)nc(Nc2ccc(F)cc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1nc(CSC(=S)N2CCOCC2)nc(Nc2ccc(F)cc2)n1
Nc1nc(CSC(=S)N2CCOCC2)nc(Nc2ccc(F)cc2)n1
[4-amino-6-(4-fluoroanilino)-1,3,5-triazin-2-yl]methyl morpholine-4-carbodithioate